New Article Published in Exploration of Digestive Diseases
We are excited to share our latest review exploring the potential of lysosomal cathepsins as therapeutic targets for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hepatocellular Carcinoma (HCC):